Abstract:Cardiac troponin I (cTnI) is a critical biomarker for the diagnosis of acute myocardial infarction (AMI). Herein, we report a novel integrated lateral flow immunoassay (LFIA) platform for highly sensitive point-of-care testing (POCT) of cTnI using hierarchical dendritic copper-nickel (HD-nanoCu-Ni) nanostructures. The electrodeposited HD-nanoCu-Ni film (∼22 μm thick) on an ITO-coated glass substrate exhibits superior capillary action and structural integrity. These properties enable efficient sample transport and antibody immobilization, making it a compelling alternative to conventional multi-component paper-based LFIA test strips, which are often plagued by structural fragility and susceptibility to moisture damage. The biofunctionalized HD-nanoCu-Ni substrates were laser-etched with lateral flow channels, including a sample loading/conjugate release zone, a test zone, and a control zone. Numerical simulations were used to further optimize the design of these channels to achieve optimal fluid flow and target capture. The HD-nanoCu-Ni LFIA device utilizes a fluorescence quenching based sandwich immunoassay format using antibody-labeled gold nanoparticles (AuNPs) as quenchers. Two different fluorescent materials, fluorescein isothiocyanate (FITC) and CdSe@ZnS quantum dots (QDs), were used as background fluorophores in the device. Upon the formation of a sandwich immunocomplex with cTnI on the HD-nanoCu-Ni device, introduced AuNPs led to the fluorescence quenching of the background fluorophores. The total assay time was approximately 15 min, demonstrating the rapid and efficient nature of the HD-nanoCu-Ni LFIA platform. For FITC, both inner filter effect (IFE) and fluorescence resonance energy transfer (FRET) contributed to the AuNP-mediated quenching. In the case of CdSe@ZnS QDs, IFE dominated the AuNP-induced quenching. Calibration curves were established based on the relationship between the fluorescence quenching intensity and cTnI concentration in human serum samples, ranging from 0.5 to 128 ng/mL. The limits of detection (LODs) were determined to be 0.27 ng/mL and 0.40 ng/mL for FITC and CdSe@ZnS QDs, respectively. A method comparison study using Passing-Bablok regression analysis on varying cTnI concentrations in human serum samples confirmed the equivalence of the HD-nanoCu-Ni LFIA platform to a commercial fluorescence cTnI LFIA assay kit, with no significant systematic or proportional bias observed.

A novel Apt-SERS platform for the determination of cardiac troponin I based on coral-like silver-modified magnetic substrate and BCA method

Aptamer-modified magnetic SERS substrate for label-based determination of cardiac troponin I

Detection of C-reactive Protein Using a Label-Free NIR Fluorescent Aptasensor with a Large Stokes Shift Based on an AIEE Anthracene Derivative

A nanoporous electrochemical aptamer-based sensors for rapid detection of cardiac troponin I in blood

A Label-Free Electrochemical Aptamer Sensor for Sensitive Detection of Cardiac Troponin I Based on AuNPs/PB/PS/GCE

Low-noise fluorescent detection of cardiac troponin I in human serum based on surface acoustic wave separation

Dual-Modular Aptasensor for Detection of Cardiac Troponin I Based on Mesoporous Silica Films by Electrochemiluminescence/Electrochemical Impedance Spectroscopy

Electrochemical Sandwich-Type Aptasensor Based on the Multifunctional Catechol-Loaded Au/MIL-53(Fe) for Detection of Cardiac Troponin I

Ferricyanide-Mediated, Electrocatalytic Mechanism of Electrochemical Aptamer-Based Sensor Supports Ultrasensitive Analysis of Cardiac Troponin I in Clinical Samples

Fouling-Free Electrochemical Strategy based on Vertically-aligned Peptide Layer for Cardiac Troponin I Sensitive Detection in Human Serum

Rational utilization of Fe(III)-2-amino terephthalic acid MOF as a bifunctional nanocarrier of dopamine and aptamer for constructing ultrasensitive sandwich biosensor of cardiac Troponin I

Aptamer-based Novel Ag-coated Magnetic Recognition and SERS Nanotags with Interior Nanogap Biosensor for Ultrasensitive Detection of Protein Biomarker

A novel double-door-opening sensor for visual determination of cardiac troponin I based on DNA hydrogel and bimetallic nanozyme

An Optical Immunosensor Based on Surface Plasmon Resonance for Human cTnI Determination

In Situ Construction of Oriented Pt‐PANI Needle‐Like Nanoarrays‐Based Label‐Free Aptasensor for Ultrafast and Ultrasensitive Recognition of Cardiac Troponin I

A Rapid and Ultrasensitive Cardiac Troponin I Aptasensor Based on an Ion-Sensitive Field-Effect Transistor with Extended Gate

Hybridization chain reaction-enhanced electrochemically mediated ATRP coupling high-efficient magnetic separation for electrochemical aptasensing of cardiac troponin I

A novel integrated lateral flow immunoassay platform for the detection of cardiac troponin I using hierarchical dendritic copper-nickel nanostructures

Development of an aptasensor for highly sensitive detection of cardiac troponin I using cobalt–nickel metal-organic framework (CoNi-MOF)

Integrating MXene/MWCNTs into aptasensor capable of ultrasensitive quantification of cTnI towards the diagnosis of acute myocardial infarction

An Electrochemical Metallic Nanowire Aptasensor for Rapid and Ultrasensitive Detection of Cardiac Troponin I